581 results on '"Kawai, Shinichi"'
Search Results
152. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
153. Interaction of RU 486, A Glucocorticoid and Progestin Antagonist with Human Circulating Mononuclear Leukocytes
154. Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
155. Clinical Activity After 12 Weeks of Treatment with Nonbiologics in Early Rheumatoid Arthritis May Predict Articular Destruction 2 Years Later
156. Systemic lupus erythematosus complicated by recurrent pneumothorax: Case report and literature review
157. 9. Reactive Arthritis
158. 8. Clinical Guidelines for Rheumatoid Arthritis.
159. This title is unavailable for guests, please login to see more information.
160. Erythrocyte Methotrexate-polyglutamate Assay Using Fluorescence Polarization Immunoassay Technique: Application to the Monitoring of Patients with Rheumatoid Arthritis
161. Prostaglandin E2 Differentially Modulates Proinflammatory/Prodestructive Effects of TNF-α on Synovial Fibroblasts via Specific E Prostanoid Receptors/cAMP
162. Preliminary Study to Identify the Predictive Factors for the Response to Methotrexate Therapy in Patients with Rheumatoid Arthritis
163. Prostaglandin E2 activates Rap1 via EP2/EP4 receptors and cAMP-signaling in rheumatoid synovial fibroblasts: Involvement of Epac1 and PKA
164. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
165. Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
166. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis
167. PGE2 mediates cAMP-dependent Epac1/Rap1 signaling in primary rheumatoid synovial fibroblasts (100.9)
168. 3. Polymyositis and Dermatomyositis
169. Development and Safety of Molecular Targeting Drugs
170. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
171. Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials.
172. Opening remarks for the 27th annual meeting of the Japanese Society of Inflammation and Regeneration
173. Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2
174. OUTLINE OF STRONG-MOTION EVALUATION IN NATIONAL SEISMIC HAZARD MAPPING PROJECT OF JAPAN
175. Prostaglandin E2is an enhancer of interleukin-1β-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts
176. Book Review: Chugoku Kigyou no Shoyuu to Keiei
177. Higher Order Approximation of the Probability Distribution of the Ratio Estimator for a Regression Model
178. Aspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cells
179. Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis in Association with Activation of Peroxisome Proliferator-Activated Receptor γ in Rheumatoid Synovial Cells
180. Effect of PGE1 on hypoxia or hypoxia/reoxygenation-treated human vascular endothelial cells
181. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes
182. A Case of Black Dot Ringworm with a Review of Japanese Cases
183. Novel Antiarthritic Agents with 1,2-Isothiazolidine-1,1-dioxide (γ-Sultam) Skeleton: Cytokine Suppressive Dual Inhibitors of Cyclooxygenase-2 and 5-Lipoxygenase
184. Genomic DNA Analysis of Thyrotropin Receptor in a Family with Hereditary Hyperthyroidism.
185. Reply
186. 18 years mitotane therapy for intractable Cushing's disease
187. Synovial fibroblast proliferation and cytokines: Possible regulation by ras gene.
188. Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells
189. Serum lipoprotein(a) concentration and phenotype in patients with systemic lupus erythematosus.
190. This title is unavailable for guests, please login to see more information.
191. Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors
192. Clinical significance of anti‐annexin V antibodies in patients with systemic lupus erythematosus
193. Low-dose Pulse Methotrexate Inhibits Articular Destruction of Adjuvant Arthritis in Rats
194. Advantages of Ultra-Thin SIMOX/CMOS based on Well-Established 0.8 µm Mass-Production Technologies for Low Power 1 V Phase Locked Loop Circuits
195. Phospholipid-Dependent Anti-.BETA.2-Glycoprotein I (.BETA.2-GPI) Antibodies and Antiphospholipid Syndrome.
196. Antisense Phosphorothioate Oligonucleotide Inhibits Interleukin 1β Production in the Human Macrophage-Like Cell Line, U937
197. Determination of the clinical optimal dose of L-377 (methotrexate capsule) for the treatment of rheumatoid arthritis.
198. Evaluation of Urinary Pyridinoline in Healthy Adults and Patients with Rheumatoid Arthritis by an Improved High-performance Liquid Chromatographic Assay.
199. Disease Distribution of β2-Glycoprotein I-Dependent Anticardiolipin Antibodies in Rheumatic Diseases
200. A case of rheumatoid arthritis complicated with salazosulfapyridine-induced aplastic anemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.